|Bid||0.3900 x 0|
|Ask||0.3950 x 0|
|Day's Range||0.3750 - 0.4150|
|52 Week Range||0.3750 - 2.3400|
|Beta (3Y Monthly)||4.22|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.25|
Vancouver, British Columbia, June 12, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon, Chief Executive.
FRA: 8IS2) announced today that Mr. Colin Kinsley has been appointed to the Board of Directors as an independent Director. Mr. Kinsley previously served on the Board of Directors of the Corporation (the “Board”) from December, 2014 to June, 2017. Mr. Trevor Dixon, the Company’s Chief Executive Officer, said, “The Company is very pleased to have Mr. Kinsley join the Board.
Today we will run through one way of estimating the intrinsic value of Invictus MD Strategies Corp. (CVE:GENE) by...
Vancouver, June 05, 2019 -- Vancouver, BC, June 5, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today.
FRA: 8IS2) announced today that Mr. Richard Lee has been appointed to the Board of Directors as an independent Director. Mr. Aaron Bowden has submitted his resignation as a Director in order to devote more time to his other business interests. Mr. Bowden will continue to serve the Company as an advisor. Mr. Bowden was appointed to the Board of Directors on August 19, 2016 and served as Chair of the Audit Committee.
FRA: 8IS2) announces that the Board of Directors (the “Board”) has accepted Mr. George E. Kveton’s resignation as Chief Executive Officer (“CEO”) of the Company and Mr. Trevor Dixon, a member of the Board, will be assuming the role of CEO. “I am proud to be serving as the Company’s CEO,” said Mr. Dixon. “I am committed to the long term and ongoing success of the Company as we work to improve production, increase revenue and decrease the cost of operations.
FRA: 8IS2) announced today that the Company is withdrawing plans to list the Company’s common shares (the “Shares”) on NASDAQ Stock Market LLC (“NASDAQ”), as well as plans for the share consolidation that would have been required to meet NASDAQ’s minimum share price listing threshold. Plans for the NASDAQ listing and a share consolidation were originally announced in press releases dated January 17, 2019 and January 21, 2019.
FRA: 8IS2) the Company is pleased to announce the appointment of Trevor Dixon as a Director and Chief Operating Officer of the Company effective immediately. Mr. Dixon is the founder, President and Chief Executive Officer of the Company's wholly owned subsidiary Acreage Pharms Ltd. ("Acreage Pharms"). "Mr. Dixon brings 35 years of successful business experience to the leadership team of Invictus," said George E. Kveton, CEO of Invictus.
Vancouver, BC, April 26, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) the Company has granted 200,000 incentive.
FRA: 8IS2) announced today that it has entered into a letter of intent (“LOI”) to form a Joint Venture (“JV”) with Gene Simmons (“Simmons”), Simmons’ MoneyBag Sodas (“MoneyBag™”) and Rock Steady Sodas, Inc. (“Rock”) (each a “Party” and collectively the “Parties”) to develop a line of non-alcoholic, CBD-infused beverages for distribution in the United States and Canada. Rock will contribute expertise with existing premium soda recipes to be used with CBD and generations of bottling and distribution experience.
It hasn't been the best quarter for Invictus MD Strategies Corp. (CVE:GENE) shareholders, since the share price has fallen 25% in that time. But in three years the returns have been great. In fact, the share price is...
Vancouver, BC, April 01, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) is pleased to have made its inaugural shipment.
Vancouver, BC, March 25, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to report that the Company’s Chief.
FRA: 8IS1) is pleased to announce that the Company’s licensed producer AB Labs Inc. (“AB Labs") has received a medical sales and processing license from Health Canada effective March 16, 2019, pursuant to the Cannabis Act and Cannabis Regulations (“CACR”). AB Labs, located in Hamilton, Ontario is at the heart of the Company’s presence in Eastern Canada, with its 16,000 square foot Phase 1 facility currently operating at full capacity, and its 40,000 square foot Phase 2 facility just weeks away from finalizing its Confirmation of Readiness submission to Health Canada.
Vancouver, BC, March 15, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce the appointment of.
FRA: 8IS1) is pleased to provide an update on its binding letter of intent to create a joint venture with Cannamerica Brands Corp. (CSE:CANA) (CNNXF) and CBDistribution Company Ltd. (collectively, the “Joint Venture”) that was previously announced on January 7, 2019, with the intention of acquiring hemp biomass for extraction into CBD isolate using purpose-built facilities for large scale CBD extraction. The transaction is anticipated to close on or before March 31, 2019. Each of the parties involved have received approval from their respective Board of Directors to enter into the Joint Venture.
FRA: 8IS1) is pleased to provide an update on production and expansion plans at its Licensed Producers: Acreage Pharms Ltd. (“Acreage Pharms”), AB Laboratories Inc. (“AB Labs”) and 0989561 B.C. Ltd. ("Canandia"). Invictus is proud to have fulfilled 100 per cent of provincial product orders to date and looks to further strengthen its sales and distribution relationships with both public and private enterprises as the Company’s facilities reach full operating capacity. A production footprint of 189,000 square feet is underway, with more capacity to come online commensurate with market needs and funding.
FRA: 8IS1) is pleased to announce that its wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), has successfully completed testing on two batches of oil and is working to finalize its application to Health Canada to allow for the sale of bottled cannabis oil and cannabis resin. Acreage Pharms' closed-loop CO2 system performs Subcritical and Supercritical Fluid Extraction utilizing high-pressure carbon dioxide to extract essential oils from botanicals, using specific temperatures and pressures to withdraw different components from plants.
FRA: 8IS1) is pleased to announce that its wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), has signed an agreement to supply the Ontario Cannabis Retail Corporation (“OCRC”), through the Ontario Cannabis Store (“OCS”), with a selection of premium cannabis products for the adult recreational market. Acreage Pharms, located in Edson, Alberta, is Invictus’ largest purpose-built indoor facility fully licensed under the Cannabis Act and Cannabis Regulations.
With over 35 years of branding experience in the healthcare sector, the Agency will leverage its expertise to help create, develop, and execute the go-to-market strategy for Invictus cannabis products. As interim CMO, the Agency will work with Authentic Brands Group (“ABG”) and Invictus’ senior leadership team to facilitate the anticipated launch of Invictus’ medical brand T2C, and adult recreational brands under Dukes and Sterling & Hunt.
LOS ANGELES, CA / ACCESSWIRE / February 1, 2019 / LD Micro is pleased to announce that the LD Micro Index is being reconstituted as of February 1, 2019. Again. We have always held the belief that our industry ...
Cannabis News Delta 9 Cannabis (OTCMKTS:VRNDF) inked a master license agreement with NanoSphere Health Sciences and its Canadian subsidiary NanoSphere Cannabis International. The agreement gives an exclusive license to Delta 9 in Canada to manufacture and sell products made with Nanosphere's patented technology for the delivery of cannabinoids via nanoparticle technology. Green Organic Dutchman Holdings […] The post Cannabis Stock News Daily Roundup January 29 appeared first on Market Exclusive.
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks, releases a snapshot focused on the CBD edibles market and how, specifically, CBD gummies are in high demand. Building on that, Transparency Market Research expects the global market for gummy vitamins to rise at a steady CAGR of 5.2% during the period between 2017 and 2025. Last November, Canopy Growth Corporation (NYSE:CGC) (TSX:WEED.TO) started selling CBD-dominant softgels through its Tweed brand, containing 20 milligrams of CBD, and between 2.5 or 10 milligrams of THC.
FRA: 8IS1) is pleased to provide an update on its binding letter of intent ("LOI") to create a joint venture with Cannamerica Brands Corp. ("CannAmerica") (CSE:CANA) (CNNXF) and CBDistribution Company Ltd. ("CBDC") (collectively the "Joint Venture") that was previously announced on January 7, 2019 with the intention of acquiring hemp biomass for extraction into CBD isolate using purpose-built facilities for large scale CBD extraction. Invictus is pleased to announce that it has received approval from its Board of Directors to enter into the Joint Venture with CannAmerica and CBDC.